Skip to results
Modify your search
NARROW
1-20 of 24
Authors: Roy M. Gulick
Journal Article
EDITOR'S CHOICE
Drug Costs: What Can Infectious Diseases Physicians Do?
The Journal of Infectious Diseases, Volume 221, Issue 5, 1 March 2020, Pages 681–684, https://doi.org/10.1093/infdis/jiz067
Published: 19 March 2019
Journal Article
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
The Journal of Infectious Diseases, Volume 218, Issue 12, 15 December 2018, Pages 1954–1963, https://doi.org/10.1093/infdis/jiy479
Published: 06 August 2018
Journal Article
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants
The Journal of Infectious Diseases, Volume 216, Issue 5, 1 September 2017, Pages 554–564, https://doi.org/10.1093/infdis/jix248
Published: 06 July 2017
Journal Article
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)
The Journal of Infectious Diseases, Volume 215, Issue 2, 15 January 2017, Pages 238–246, https://doi.org/10.1093/infdis/jiw525
Published: 02 November 2016
Journal Article
Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study Get access
The Journal of Infectious Diseases, Volume 202, Issue 5, 1 September 2010, Pages 717–722, https://doi.org/10.1086/655470
Published: 01 September 2010
Journal Article
Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure Get access
The Journal of Infectious Diseases, Volume 201, Issue 5, 1 March 2010, Pages 662–671, https://doi.org/10.1086/650543
Published: 01 March 2010
Journal Article
Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211 Get access
The Journal of Infectious Diseases, Volume 200, Issue 11, 1 December 2009, Pages 1724–1728, https://doi.org/10.1086/648090
Published: 01 December 2009
Journal Article
Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects Get access
The Journal of Infectious Diseases, Volume 200, Issue 4, 1 August 2009, Pages 614–618, https://doi.org/10.1086/600890
Published: 01 August 2009
Journal Article
Efavirenz-Based Regimens in Treatment-Naive Patients with a Range of Pretreatment HIV-1 RNA Levels and CD4 Cell Counts Get access
The Journal of Infectious Diseases, Volume 197, Issue 7, 1 April 2008, Pages 1006–1010, https://doi.org/10.1086/529208
Published: 01 April 2008
Journal Article
Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Subjects Get access
The Journal of Infectious Diseases, Volume 197, Issue 6, 15 March 2008, Pages 867–870, https://doi.org/10.1086/528802
Published: 15 March 2008
Journal Article
Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211 Get access
The Journal of Infectious Diseases, Volume 196, Issue 2, 15 July 2007, Pages 304–312, https://doi.org/10.1086/518797
Published: 15 July 2007
Journal Article
Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside or Efavirenz-Containing Regimens: ACTG A5166s Get access
The Journal of Infectious Diseases, Volume 195, Issue 8, 15 April 2007, Pages 1169–1176, https://doi.org/10.1086/512619
Published: 15 April 2007
Journal Article
A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug-Resistant HIV: 48-Week Virologic Results of ACTG A5086 Get access
The Journal of Infectious Diseases, Volume 194, Issue 9, 1 November 2006, Pages 1309–1318, https://doi.org/10.1086/508289
Published: 01 November 2006
Journal Article
Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus Get access
The Journal of Infectious Diseases, Volume 192, Issue 11, 1 December 2005, Pages 1943–1949, https://doi.org/10.1086/497608
Published: 01 December 2005
Journal Article
Weighted Phenotypic Susceptibility Scores Are Predictive of the HIV-1 RNA Response in Protease Inhibitor-Experienced HIV-1-Infected Subjects Get access
The Journal of Infectious Diseases, Volume 190, Issue 5, 1 September 2004, Pages 886–893, https://doi.org/10.1086/422692
Published: 01 September 2004
Journal Article
Sex-Based Differences in Saquinavir Pharmacology and Virologic Response in AIDS Clinical Trials Group Study 359 Get access
The Journal of Infectious Diseases, Volume 189, Issue 7, 1 April 2004, Pages 1176–1184, https://doi.org/10.1086/382754
Published: 01 April 2004
Journal Article
Short-Term Safety and Antiretroviral Activity of T-1249, a Second-Generation Fusion Inhibitor of HIV Get access
The Journal of Infectious Diseases, Volume 189, Issue 6, 15 March 2004, Pages 1075–1083, https://doi.org/10.1086/381707
Published: 15 March 2004
Journal Article
Durability of Response to Treatment among Antiretroviral-Experienced Subjects: 48-Week Results from AIDS Clinical Trials Group Protocol 359 Get access
The Journal of Infectious Diseases, Volume 186, Issue 5, 1 September 2002, Pages 626–633, https://doi.org/10.1086/342681
Published: 01 September 2002
Journal Article
The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850) Get access
The Journal of Infectious Diseases, Volume 186, Issue 2, 15 July 2002, Pages 198–204, https://doi.org/10.1086/341209
Published: 15 July 2002
Journal Article
Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients Get access
The Journal of Infectious Diseases, Volume 185, Issue 5, 1 March 2002, Pages 599–607, https://doi.org/10.1086/339014
Published: 01 March 2002
